GlassScriptPhysician profile
Nasim Ahmed
NPI 1841266780
$741.71
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.05 · 2020: $97.88 · 2021: $41.71 · 2022: $159 · 2023: $75.10 · 2024: $92.73 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $145.01 | 2022 | |
| Davol INC. | $76.31 | 2019-2021 | |
| Tela Bio, INC. | $66.89 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Csl Behring | $66.43 | 2019-2020 | |
| Teleflex LLC | $63.16 | 2024 | Arrow |
| Z-Medica, LLC | $46.81 | 2019 | |
| Kerecis Limited | $40.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Convatec INC. | $36.89 | 2023 | |
| Smith+Nephew, INC. | $32.47 | 2020-2025 | Stravix Pl, Oasis, Grafix |
| Acera Surgical, INC. | $29.57 | 2024 | Restrata Wound Matrix |
| Ge Healthcare | $21.42 | 2023 | |
| La Jolla Pharmaceutical Company | $19.02 | 2025 | Giapreza |
| Mesh Suture INC | $18.31 | 2025 | |
| Chiesi USA, INC. | $17.52 | 2025 | Cleviprex |
| Depuy Synthes Sales INC. | $17.30 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $16.79 | 2023 | |
| Boston Scientific Corporation | $14.05 | 2022 | |
| Portola Pharmaceuticals, LLC | $12.79 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nasim Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.